IRIDEX Corporation (IRIX)

NASDAQ
6.460
0.000(0.00%)
  • Volume:
    2,780
  • Bid/Ask:
    6.420/6.500
  • Day's Range:
    6.410 - 6.460

IRIX Overview

Prev. Close
6.46
Day's Range
6.41-6.46
Revenue
39.28M
Open
6.43
52 wk Range
1.6-9.715
EPS
-0.48
Volume
2,780
Market Cap
100.94M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
61,862
P/E Ratio
-
Beta
1.25
1-Year Change
212.08%
Shares Outstanding
15,625,800
Next Earnings Date
Aug 05, 2021
What is your sentiment on IRIDEX Corporation?
or
Vote to see community's results!

IRIDEX Corporation News

IRIDEX Corporation Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuySellStrong SellBuy
Technical IndicatorsBuyBuyNeutralStrong SellStrong Buy
SummaryBuyBuyNeutralStrong SellStrong Buy

IRIDEX Corporation Company Profile

IRIDEX Corporation Company Profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Read More
  • #Biolase check - target price 5$ 🧨
    1
    • y u promoting biolase when its just going down
      0
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.